Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
S-phase kinase-associated protein 1 pseudogene 1 (SKP1P1)
- Target
- SKP1P1
- Molecular classification
- Other (Pseudogene; not part of established drug target families such as receptor, enzyme, transporter, ion channel, etc.)
01
Overview
SKP1P1, or S-phase kinase-associated protein 1 pseudogene 1, is classified as a pseudogene in the human genome[1][2][6]. Pseudogenes are genomic DNA sequences similar to normal genes but are not transcribed into functional proteins. While some pseudogenes can impact cellular processes by acting as decoys for microRNAs, participating in RNA interference, or modifying expression of related genes, SKP1P1 has no evidence of direct involvement in these functions or in disease. Importantly, EMC19 in this context refers to a pseudogene and not the endoplasmic reticulum membrane protein complex subunit 19, a distinct protein. There is no basis to consider SKP1P1 a therapeutic target, druggable receptor, enzyme, transporter, or similar molecule[1][2][6]. In summary, SKP1P1 is a human pseudogene, not a canonical target for pharmacological or clinical intervention. Its listing as a target is incorrect for drug development or biomarker applications.
- Other names
- EMC19OCP2TCEB1LTCEB1PTCEB1P1
02
Biological functions
Other (Pseudogenes can regulate gene expression by acting as competing endogenous RNAs, sources of small interfering RNAs, and influence biological pathways; SKP1P1 itself has no documented direct biological function)
03
Disease associations
Other (While some pseudogenes can be involved in disease via gene regulation or recombination effects, there is no documentation associating SKP1P1 specifically with any disease)
Beyond the preview
Go deeper on S-phase kinase-associated protein 1 pseudogene 1 (SKP1P1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on S-phase kinase-associated protein 1 pseudogene 1 (SKP1P1).